Treatment of Hidradenitis Suppurativa with Adalimumab in the PIONEER I and II Trials Reduced Indices of Systemic Inflammation, Recognised Risk Factors for Cardiovascular Disease

Clinical and Experimental Dermatology(2024)

Cited 0|Views0
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined